Research graph
References from Getting hands on a drug for Covid-19: Inhaled and Intranasal Niclosamide. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.lanepe.2021.100084 · Admitted local publication
Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects
10.1371/journal.ppat.1002976 · 2012 · External reference
Drug repurposing: the anthelmintics niclosamide and nitazoxanide are potent TMEM16A antagonists that fully bronchodilate airways
10.3389/fphar.2019.00051 · 2019 · External reference
TMEM16A in cystic fibrosis: activating or inhibiting?
10.3389/fphar.2019.00003 · 2019 · External reference
Niclosamide repurposed for the treatment of inflammatory airway disease
2019 · External reference
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus
10.1371/journal.pone.0124595 · 2015 · External reference
COVID-19 vaccines: “Warp Speed” needs mind melds, not warped minds
10.1128/jvi.01083-20 · 2020 · External reference
Maintaining safety with SARS-CoV-2 vaccines
10.1056/nejmra2035343 · 2021 · External reference
Covid-19 and immunity in aging populations - a new research agenda
10.1056/nejmp2006761 · 2020 · External reference
The potential danger of suboptimal antibody responses in COVID-19
10.1038/s41577-020-0321-6 · 2020 · External reference
